Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study (Q74265775)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 2000

Language	Label	Description	Also known as
English	Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study	scientific article published on 01 July 2000

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

Sverre E. Kjeldsen

4

object named as

S E Kjeldsen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

8

object named as

U de Faire

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

L Hansson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T Hedner

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Lund-Johansen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L H Lindholm

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J O Syvertsen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Lanke

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B Dahlöf

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B E Karlberg

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

356

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

9227

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

359-365

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

The Nordic Diltiazem Study (NORDIL). A prospective intervention trial of calcium antagonist therapy in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Shanghai trial of nifedipine in the elderly (STONE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term diltiazem treatment on central haemodynamics and exercise endurance in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902526-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02526-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10972367%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74265775&oldid=1757991382"